Internet-based System for Cancer Patients to Self-report Toxicity
| Status: | Completed |
|---|---|
| Conditions: | Breast Cancer, Lung Cancer, Prostate Cancer, Ovarian Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cancer, Women's Studies, Bladder Cancer |
| Therapuetic Areas: | Oncology, Reproductive |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/11/2017 |
| Start Date: | March 2004 |
| End Date: | January 2017 |
Pilot Study of STAR, an Internet-based System for Cancer Patients to Self-report Toxicity Symptoms, Performance Status, and Quality of Life
Cancer patients may develop side effects during treatment, such as nausea, pain, fatigue,
diarrhea, constipation, or shortness of breath. These symptoms may be due to the cancer
itself, or due to treatments like chemotherapy drugs or radiation therapy. Doctors and
nurses often ask patients about their symptoms, because an important part of cancer
treatment is to make patients feel as well as possible. If patients do not feel well, the
investigators may need to change the way the investigators are treating you or prescribe
therapies that will decrease your symptoms. The best way to find out how you are feeling is
to ask you directly.
However, during your time between appointments the investigators may not be able to ask you
how you are feeling on a regular basis. In addition, even at an appointment, there may be
symptoms that the investigators do not have a chance to discuss.
The investigators are interested in developing new ways to ask patients about how they are
feeling, using the Internet. A special new website called STAR ("Symptom Tracking and
Reporting for Patients") has been developed to help patients record this information, so
that their doctors and nurses can review it during clinic appointments. This study is
designed to help us see if STAR is a helpful way for us to keep track of information about
patients' symptoms and quality of life.
diarrhea, constipation, or shortness of breath. These symptoms may be due to the cancer
itself, or due to treatments like chemotherapy drugs or radiation therapy. Doctors and
nurses often ask patients about their symptoms, because an important part of cancer
treatment is to make patients feel as well as possible. If patients do not feel well, the
investigators may need to change the way the investigators are treating you or prescribe
therapies that will decrease your symptoms. The best way to find out how you are feeling is
to ask you directly.
However, during your time between appointments the investigators may not be able to ask you
how you are feeling on a regular basis. In addition, even at an appointment, there may be
symptoms that the investigators do not have a chance to discuss.
The investigators are interested in developing new ways to ask patients about how they are
feeling, using the Internet. A special new website called STAR ("Symptom Tracking and
Reporting for Patients") has been developed to help patients record this information, so
that their doctors and nurses can review it during clinic appointments. This study is
designed to help us see if STAR is a helpful way for us to keep track of information about
patients' symptoms and quality of life.
This pilot study will assess patient use of STAR (Symptom Tracking and Reporting for
Patients), an online system designed for cancer patients to self-record toxicity-related
symptoms based on NCI Common Terminology Criteria for Adverse Events v3.0, performance
status by ECOG criteria, global quality of life by the EuroQOL 5-D assessment tool,
emergency room visits, and survival. Secondary outcomes will include patient assessment of
the usefulness of STAR, clinician perceptions of the potential value of STAR in routine
clinical practice, and an evaluation of whether STAR improves the patient experience of care
as assessed by satisfaction measures.
Patients), an online system designed for cancer patients to self-record toxicity-related
symptoms based on NCI Common Terminology Criteria for Adverse Events v3.0, performance
status by ECOG criteria, global quality of life by the EuroQOL 5-D assessment tool,
emergency room visits, and survival. Secondary outcomes will include patient assessment of
the usefulness of STAR, clinician perceptions of the potential value of STAR in routine
clinical practice, and an evaluation of whether STAR improves the patient experience of care
as assessed by satisfaction measures.
Inclusion Criteria:
- Age >18 years
- Diagnosis of gynecologic (ovarian; cervical; uterine; primary peritoneal), lung
(non-small cell; small cell), gastrointestinal (colorectal, rectal, gastric,
esophageal, GI neuroendocrine, small intestine malignancy, pancreatic,
hepatocellular), breast, bladder cancer or prostate malignancy
- Receiving primary medical oncology care at MSKCC medical oncology outpatient clinics
- Receiving cytotoxic chemotherapy not on a clinical trial (or a new hormonal therapy
in the case of prostate cancer patients only), with treatment expected to continue
for at least four weeks from the time of enrollment
- Signed informed consent and Research Authorization
Exclusion Criteria:
- ECOG performance status greater than 2
- Unable to read and comprehend English language text
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
